TheNote.app
STAT | Reporting from the frontiers of health and medicine

STAT+: Pharmalittle: We’re reading about AstraZeneca investing in China, an abandoned overdose antidote, and more

AstraZeneca will invest $15 billion in China through 2030 to expand medicines manufacturing and research and development
favicon
statnews.com
statnews.com
Image for the article: STAT+: Pharmalittle: We’re reading about AstraZeneca investing in China, an abandoned overdose antidote, and more
RSS Hunter
Create attached notes ...